These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

799 related articles for article (PubMed ID: 25312641)

  • 1. Emerging treatment strategies for glioblastoma multiforme.
    Carlsson SK; Brothers SP; Wahlestedt C
    EMBO Mol Med; 2014 Nov; 6(11):1359-70. PubMed ID: 25312641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.
    Polivka J; Polivka J; Holubec L; Kubikova T; Priban V; Hes O; Pivovarcikova K; Treskova I
    Anticancer Res; 2017 Jan; 37(1):21-33. PubMed ID: 28011470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Current State of Potential Therapeutic Modalities for Glioblastoma Multiforme: A Clinical Review.
    Mohtashami E; Shafaei-Bajestani N; Mollazadeh H; Mousavi SH; Jalili-Nik M; Sahebkar A; Afshari AR
    Curr Drug Metab; 2020; 21(8):564-578. PubMed ID: 32664839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioblastoma Multiforme, Diagnosis and Treatment; Recent Literature Review.
    Batash R; Asna N; Schaffer P; Francis N; Schaffer M
    Curr Med Chem; 2017; 24(27):3002-3009. PubMed ID: 28521700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioblastoma biomarkers from bench to bedside: advances and challenges.
    Farias-Eisner G; Bank AM; Hwang BY; Appelboom G; Piazza MA; Bruce SS; Sander Connolly E
    Br J Neurosurg; 2012 Apr; 26(2):189-94. PubMed ID: 22176646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoformulations for glioblastoma multiforme: a new hope for treatment.
    Ortiz R; Cabeza L; Perazzoli G; Jimenez-Lopez J; García-Pinel B; Melguizo C; Prados J
    Future Med Chem; 2019 Sep; 11(18):2459-2480. PubMed ID: 31544490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized regulation of glioblastoma cancer stem cells based on biomedical technologies: From theory to experiment (Review).
    Bryukhovetskiy I; Ponomarenko A; Lyakhova I; Zaitsev S; Zayats Y; Korneyko M; Eliseikina M; Mischenko P; Shevchenko V; Shanker Sharma H; Sharma A; Khotimchenko Y
    Int J Mol Med; 2018 Aug; 42(2):691-702. PubMed ID: 29749540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology to augment immunotherapy for the treatment of glioblastoma multiforme.
    Ung N; Yang I
    J Neurooncol; 2015 Jul; 123(3):473-81. PubMed ID: 26070553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers and Immunotherapeutic Targets in Glioblastoma.
    Hung AL; Garzon-Muvdi T; Lim M
    World Neurosurg; 2017 Jun; 102():494-506. PubMed ID: 28300714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioblastoma multiforme: a review of therapeutic targets.
    Kanu OO; Mehta A; Di C; Lin N; Bortoff K; Bigner DD; Yan H; Adamson DC
    Expert Opin Ther Targets; 2009 Jun; 13(6):701-18. PubMed ID: 19409033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of immunotherapy resistance: lessons from glioblastoma.
    Jackson CM; Choi J; Lim M
    Nat Immunol; 2019 Sep; 20(9):1100-1109. PubMed ID: 31358997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult Glioblastoma.
    Alexander BM; Cloughesy TF
    J Clin Oncol; 2017 Jul; 35(21):2402-2409. PubMed ID: 28640706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cold Atmospheric Plasma as an Adjunct to Immunotherapy for Glioblastoma Multiforme.
    Almeida ND; Klein AL; Hogan EA; Terhaar SJ; Kedda J; Uppal P; Sack K; Keidar M; Sherman JH
    World Neurosurg; 2019 Oct; 130():369-376. PubMed ID: 31284051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioblastoma: Overview of Disease and Treatment.
    Davis ME
    Clin J Oncol Nurs; 2016 Oct; 20(5 Suppl):S2-8. PubMed ID: 27668386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide vaccines for the treatment of glioblastoma.
    Swartz AM; Batich KA; Fecci PE; Sampson JH
    J Neurooncol; 2015 Jul; 123(3):433-40. PubMed ID: 25491947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioblastoma multiforme: Pathogenesis and treatment.
    Alifieris C; Trafalis DT
    Pharmacol Ther; 2015 Aug; 152():63-82. PubMed ID: 25944528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different T-cell subsets in glioblastoma multiforme and targeted immunotherapy.
    Wang H; Zhou H; Xu J; Lu Y; Ji X; Yao Y; Chao H; Zhang J; Zhang X; Yao S; Wu Y; Wan J
    Cancer Lett; 2021 Jan; 496():134-143. PubMed ID: 33022290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of multifocal and multicentric glioblastoma.
    Li Y; Zhang ZX; Huang GH; Xiang Y; Yang L; Pei YC; Yang W; Lv SQ
    J Clin Neurosci; 2021 Jan; 83():71-76. PubMed ID: 33358091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Immunotherapies for Glioblastoma Multiforme.
    Huang B; Li X; Li Y; Zhang J; Zong Z; Zhang H
    Front Immunol; 2020; 11():603911. PubMed ID: 33767690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Present and Future of Anti-Glioblastoma Therapies: A Deep Look into Molecular Dependencies/Features.
    Kim HJ; Kim DY
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33053763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.